Compare

Natera vs Labcorp

MonkScore ranges and fundamentals, side by side

Key facts

Natera and Labcorp: key facts

  • In fiscal 2025, Natera, Inc. reported revenue of $2.3B and net income of -$208.2M.
  • In fiscal 2025, Labcorp Holdings Inc. reported revenue of $14.0B and net income of $876.5M.
  • Natera, Inc.'s revenue grew 38.6% a year from fiscal 2021 to fiscal 2025.
  • Labcorp Holdings Inc.'s revenue grew 1.5% a year from fiscal 2021 to fiscal 2025.
  • Natera, Inc.'s free cash flow was positive in 2 of the 5 fiscal years from 2021 to 2025.
  • Labcorp Holdings Inc.'s free cash flow was positive in 5 of the 5 fiscal years from 2021 to 2025.
  • In the twelve months to 30 June 2026, Natera, Inc. reported revenue of $2.7B and net income of -$192.3M.
  • In the twelve months to 30 September 2026, Labcorp Holdings Inc. reported revenue of $14.6B and net income of $1.0B.

Side by side

Natera and Labcorp, side by side

Each figure is in the company's reporting currency, with its fiscal year or the date of its last report.

FigureNatera, Inc.NASDAQ:NTRALabcorp Holdings Inc.NYSE:LH
MonkScore
MonkScore range70–80as of October 202650–60as of October 2026
Sector rank208 of 628 in Healthcare301 of 628 in Healthcare
How this score is madeDisclaimer
Profile
SectorHealthcareHealthcare
IndustryMedical - Diagnostics & ResearchMedical - Diagnostics & Research
Latest fiscal year
Revenue$2.3BFY 2025$14.0BFY 2025
Net income-$208.2MFY 2025$876.5MFY 2025
Free cash flow$109.1MFY 2025$1.2BFY 2025
Operating cash flow$215.3MFY 2025$1.6BFY 2025
Total debt$214.4MFY 2025$7.2BFY 2025
Cash$1.1BFY 2025$532.3MFY 2025
Last 12 months
Revenue$2.7Bto 30 June 2026$14.6Bto 30 September 2026
Net income-$192.3Mto 30 June 2026$1.0Bto 30 September 2026
Free cash flow$71.7Mto 30 June 2026$1.3Bto 30 September 2026
Operating cash flow$228.2Mto 30 June 2026$1.8Bto 30 September 2026
Total debt$238.5Mto 30 June 2026$6.8Bto 30 September 2026
Cash$1.1Bto 30 June 2026$261.8Mto 30 September 2026

MonkStreet provides research, not investment advice.